News
In brief
BMJ 2005; 330 doi: https://doi.org/10.1136/bmj.330.7498.982 (Published 28 April 2005) Cite this as: BMJ 2005;330:982
Epilepsy drug trials to be reviewed: The US Food and Drugs Administration is calling on all manufacturers of epilepsy drugs to review their trial databases to see whether any possible link with suicide is shown. The call comes after claims by the New York personal injury lawyers Finkelstein and Partners that gabapentin (Neurontin), a Pfizer product that …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.